Tirzepatide — dual GIP/GLP-1 receptor agonist research compound
Tirzepatide is a synthetic 39-amino-acid peptide that acts on two incretin receptors at once: the GIP receptor and the GLP-1 receptor. That dual action sets tirzepatide apart from classic GLP-1 analogues and makes it a heavily studied molecule in research into glucose handling, insulin secretion and energy balance.
Product information
- ✅ High purity — pharmaceutical-grade quality
- ✅ Available in 10MG per vial
- ✅ Lyophilised (freeze-dried) for maximum stability
- ✅ In stock — shipped the same day on orders before 17:00
- ✅ Discreetly packaged
Scientific background
Tirzepatide is built around a GIP-like amino-acid chain with a C20 fatty-acid chain attached to the molecule. That acylation drives binding to albumin, so the peptide breaks down considerably more slowly and has a long duration of action. In the scientific literature tirzepatide is studied mainly in research into incretin signalling, insulin and glucagon response, gastric emptying and metabolic processes around body composition.
Why 10MG?
- 10MG — a generous vial size, enough for a full research protocol
- Measured out accurately after reconstitution, with minimal residual loss per vial
Storage
Store unreconstituted at 2–8°C, dark and dry. After reconstitution with bacteriostatic water, store at 4°C and use within two to four weeks. Avoid repeated freezing and thawing.
Reviews
There are no reviews yet.